The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Xadago
safinamide mesylate · SAFINAMIDE MESYLATE 100 mg/1 · Tablet, Film Coated · Oral · MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
NDC 27505-0111-14 · 1 BLISTER PACK in 1 CARTON / 14 TABLET, FILM COATED in 1 BLISTER PACK · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.0%chance of a new FDA shortage posting for safinamide mesylate (oral solid) in the next 90 days
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $1,750.97 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA207145
- TE code
- AB
- Approval date
- Mar 21, 2017
- Patents / exclusivity
- 6 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 8283380 | Mar 21, 2031 |
| patent | 8283380 | Mar 21, 2031 |
| patent | 8076515 | Dec 10, 2028 |
| patent | 8076515 | Dec 10, 2028 |
| patent | 8278485 | Jun 8, 2027 |
| patent | 8278485 | Jun 8, 2027 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of safinamide mesylate (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc. | SAFINAMIDE MESYLATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc. | SAFINAMIDE MESYLATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Xadago — NDC 27505-0111-14," retrieved September 3, 2026, https://drugdashboards.com/drug/27505011114.
Free to cite with attribution — see how the data is put together.